Hibsago is viewed as a potential “functional cure” for chronic infections and an important part of the British drugmaker’s ...
Shortly after winning a clearance in the skin disease dermatomyositis, brepocitinib posted results suggesting it might also ...
Today, a brief rundown of news involving Arcus Biosciences and Eli Lilly, as well as updates from TriGemX Bio and AstraZeneca that you may have missed. Eli Lilly is teaming up with Hong Kong-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results